Berlin neuroscience SME specializing in sensorimotor cognition and visual neuroscience research within large European consortia.
Whitematter Labs GmbH is a Berlin-based neuroscience and neurotechnology SME whose name directly references white matter — the brain's connectivity tissue — signaling deep expertise in neural systems and brain research. The company contributed to EU research on sensorimotor contingencies (how biological and artificial agents learn through sensory-motor coupling) and to a European doctoral training network in visual neuroscience, suggesting capabilities in computational modeling, experimental neuroscience, or brain-inspired technology development. In both projects they operated as a specialist partner rather than a consortium leader, most likely providing domain-specific scientific or technical expertise that larger academic partners could not supply internally. Their presence in a FET (Future and Emerging Technologies) project indicates they engage with genuinely frontier science at the boundary of neuroscience and artificial cognition.
Participation in socSMCs (Socialising Sensori-Motor Contingencies, 2015–2019) under the FET pillar, focused on how sensory-motor coupling governs adaptive behavior in biological and artificial agents.
Participation in NextGenVis (2015–2019), a Marie Skłodowska-Curie training network dedicated to advancing European visual neuroscience research with applications in health and innovation.
Both projects sit under Research Excellence pillars (FET and MSCA) and the company name explicitly references brain white matter, pointing to broader neurotechnology or computational neuroscience capabilities.
NextGenVis is an MSCA Innovative Training Network (ETN), indicating Whitematter Labs has contributed to European-level doctoral training in visual neuroscience alongside academic institutions.
Both H2020 projects began in 2015 and ran through 2019, meaning there is no temporal spread within this dataset to track thematic shifts. No project keywords are available in the CORDIS record, making it impossible to identify a genuine change in focus from the data alone. What can be observed is that even in their earliest visible H2020 activity, the organization already operated across two distinct neuroscience streams — sensorimotor cognition and visual neuroscience — suggesting breadth rather than a narrowly defined single-discipline niche from the outset.
With both projects running in the same 2015–2019 window and no more recent H2020 data available, the trajectory is unclear — a prospective collaborator should investigate whether Whitematter Labs has continued into Horizon Europe or pivoted toward commercial neurotechnology applications since 2019.
Whitematter Labs has participated exclusively as a consortium partner and has never led an H2020 project, which is typical for a small specialist firm contributing targeted expertise rather than administrative or financial capacity. Across just two projects they engaged with 22 unique partners across 8 countries, indicating that both consortia were sizeable — consistent with an MSCA training network and a FET collaborative research project. This profile suggests they are well-suited to operating as a defined specialist node within large, multi-national European teams.
Through only 2 projects, Whitematter Labs reached 22 unique consortium partners across 8 countries, reflecting participation in large pan-European research consortia rather than small bilateral collaborations. Their network is concentrated in the academic neuroscience and Research Excellence community, with a European geographic footprint.
As a private SME explicitly named after brain white matter and active in both FET-funded cognitive systems research and an MSCA neuroscience training network, Whitematter Labs occupies a rare intersection between fundamental brain science and the technology industry. For a consortium needing a company-side partner that bridges academic neuroscience and applied or commercial angles — satisfying the 'industry partner' requirement in competitive calls — they offer scientific credibility without the overhead or bureaucracy of a large corporate. Their Berlin location also places them within one of Europe's strongest life-sciences and digital startup ecosystems, with access to a dense local research network.
